Trastuzumab 150mg, 440mg Injection
Trastuzumab 150mg, 440mg injection is used for the treatment of breast cancer, multiple myeloma, and ovarian cancer. The injection is used as an adjunct treatment for cancer. The medicine is also helpful in the treatment with medicines like doxorubicin, cyclophosphamide, paclitaxel, and docetaxel. The medication comes under the international brand of Herceptin and an Indian brand name of hertraz.
Trastumab 150mg,440mg injection comes under the category of alkylating agents. This medication works by stopping the growth of cancer cells in the user body. this medication is useful in controlling the multiplication of cancer cells.
Drug interactions are observed with this injection is of prescription type or non-prescription type. Always take the advice of the doctor for starting and stopping any kind of other drugs with this injection. This will ensure minimum side-effects in the body. nalidixic acid can be taken with this injection.
1. What is Hertraz?
Hertraz is an anti-cancer medicine containing trastuzumab, a recombinant humanized monoclonal antibody that targets the HER2 (human epidermal growth factor receptor 2) protein. It is used as a targeted therapy for certain HER2-positive cancers.
2. What is Hertraz used for?
Hertraz (trastuzumab) is used in the treatment of certain HER2-positive breast cancers and HER2-positive gastric or gastroesophageal junction cancers, depending on the approved indication and treatment protocol in the relevant market. HER2 status is generally established through appropriate diagnostic testing before treatment.
3. How does Hertraz work?
Trastuzumab binds to the HER2 receptor on cancer cells and interferes with HER2-mediated signaling involved in cell growth and survival. This targeted mechanism can help inhibit the growth of HER2-positive cancer cells.
4. What strengths of Hertraz are available?
Hertraz is available in presentations including 150 mg and 440 mg powder for concentrate for solution for intravenous infusion. Product availability, packaging and regulatory requirements may vary according to the destination country.
5. How is Hertraz administered?
Hertraz is administered through intravenous infusion by a qualified healthcare professional. The dosage and treatment schedule depend on the cancer type, treatment regimen, body weight and clinical condition. It should not be self-administered.